文献速递神经核医学肿瘤 PET/CT

疑似颅内脑膜瘤患者生长抑素受体PET/CT与组织病理学相关性的回顾性评价

Retrospective Evaluation of the Correlation Between Somatostatin Receptor PET/CT and Histopathology in Patients with Suspected Intracranial Meningiomas.
PubMed 文献 · J Nucl Med · 2025-10-01

该回顾性研究分析了2006至2021年间223次因疑似脑膜瘤行SSTR PET/CT的检查,240个病灶与4个月内组织病理学结果匹配。SSTR PET/CT诊断脑膜瘤的灵敏度为100%(95%CI 98.4%-100%),特异度为61.1%(95%CI 35.8%-82.7%),阳性预测值96.9%(95%CI 93.8%-98.8%),阴性预测值100%(95%CI 71.5%-100%),总体诊断准确率97.1%。作者结论认为SSTR PET/CT是检测颅内脑膜瘤的精确影像方法,但2.9%的病例PET/CT阳性而组织病理学未确认脑膜瘤。

要点

  • SSTR PET/CT检测脑膜瘤灵敏度100%(95%CI 98.4%-100%),特异度61.1%(95%CI 35.8%-82.7%)。
  • 240个病灶中222个(92.5%)经SSTR PET/CT准确识别并由组织病理学确认。
  • SUVmax预测组织病理学结果的ROC曲线下面积为94%。

核心结论

  • SSTR PET/CT是检测颅内脑膜瘤的精确影像方法,表现为高灵敏度。
  • 2.9%的病例尽管PET/CT阳性,组织病理学未确认脑膜瘤存在。
  • 整合MRI、组织病理学和SSTR PET/CT有助于支持知情的治疗决策。

研究设计与样本

  • 回顾性分析2006至2021年间本机构数据库记录的8077次SSTR影像检查。
  • 其中223次SSTR PET/CT因疑似脑膜瘤而进行,240个病灶与4个月内组织病理学结果匹配。
  • 回顾性审阅SSTR PET/CT报告与组织病理学结果以评估颅内脑膜瘤的存在,并计算诊断效能指标及每个病灶的SUVmax、SUVmean和SUVpeak。

主要发现

  • 240个病灶中222个(92.5%)经SSTR PET/CT准确识别并由组织病理学确认脑膜瘤。
  • 7例(2.9%)SSTR PET/CT疑似脑膜瘤但组织病理学未确认(假阳性)。
  • 11例(5%)SSTR PET/CT未疑似脑膜瘤且组织病理学未确认(真阴性)。
  • 本队列中无假阴性发现。
  • SSTR PET/CT检测脑膜瘤的灵敏度为100%(95%CI 98.4%-100%),特异度为61.1%(95%CI 35.8%-82.7%),阳性预测值为96.9%(95%CI 93.8%-98.8%),阴性预测值为100%(95%CI 71.5%-100%),总体诊断准确率为97.1%。

关键数值与推荐

  • 灵敏度100%(95%CI 98.4%-100%),特异度61.1%(95%CI 35.8%-82.7%)。
  • 阳性预测值96.9%(95%CI 93.8%-98.8%),阴性预测值100%(95%CI 71.5%-100%)。
  • 总体诊断准确率97.1%。
  • SUVmax预测组织病理学结果的ROC曲线下面积为94%。

临床怎么用

  • 作者结论认为SSTR PET/CT是检测颅内脑膜瘤的精确影像方法,表现为高灵敏度。
  • 作者指出2.9%的病例尽管PET/CT阳性,组织病理学未确认脑膜瘤存在。
  • 作者认为整合MRI、组织病理学和SSTR PET/CT有助于支持知情的治疗决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The aim of this retrospective study was to evaluate the correlation between findings from somatostatin receptor (SSTR) PET/CT and histopathology in patients with suspected intracranial meningiomas. Methods: We conducted a retrospective analysis of 8,077 SSTR imaging studies recorded in our institutional database between 2006 and 2021. In total, 223 SSTR PET/CT scans were performed for suspected meningioma, and 240 lesions were matched with histopathology results within 4 mo. Reports from SSTR PET/CT scans and histopathology were retrospectively reviewed to assess the presence of intracranial meningiomas. The positive and negative predictive values, sensitivity, specificity, and overall diagnostic accuracy of SSTR PET/CT were calculated. The SUVmax, SUVmean, and SUVpeak were determined for each lesion. Results: In 222 (92.5%) of 240 lesions, meningioma was accurately identified by SSTR PET/CT and confirmed by histopathology. In 7 cases (2.9%), SSTR PET/CT suspected meningioma was not confirmed by histopathology (false-positive). Furthermore, in 11 cases (5%), meningioma was neither suspected by SSTR PET/CT nor confirmed by histopathology (true-negative result). There were no false-negative findings in our cohort. SSTR PET/CT demonstrated a sensitivity of 100% (95% CI, 98.4%-100%) and a specificity of 61.1% (95% CI, 35.8%-82.7%) in detecting meningiomas. Positive predictive value was 96.9% (95% CI, 93.8%-98.8%), and negative predictive value was 100% (95% CI, 71.5%-100%). The overall diagnostic accuracy was 97.1%. The receiver-operating-characteristic analysis for SUVmax in predicting histopathology results showed an area under the curve of 94%, indicating an excellent ability of SUVmax to distinguish between positive and negative histopathologic findings. Conclusion: SSTR PET/CT is a precise imaging modality for detecting intracranial meningiomas, as demonstrated by its high sensitivity. However, in 2.9% of cases, despite a positive PET/CT result, histopathology did not confirm the presence of a meningioma. Integration of MRI, histopathology, and SSTR PET/CT supports informed treatment decisions.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Ebner R, Braach J, Rübenthaler J, et al. Retrospective Evaluation of the Correlation Between Somatostatin Receptor PET/CT and Histopathology in Patients with Suspected Intracranial Meningiomas. J Nucl Med. 2025. PMID: 40935608. doi:10.2967/jnumed.125.270115

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。